Oncolytic virotherapy with RIGVIR® is reimbursable medication

Oncolytic virotherapy with RIGVIR® is included in the list of reimbursable state-funded medical products in Latvia for skin melanoma patients.

Contacts for Media Inquiries

Rigvir Group
Address: Atlasa street 7C, Riga, Latvia, LV-1026
Phone: +371 67 716 132
E-mail: pr@rigvir.com